WASHINGTON (Reuters) - The U.S. Food and Drug Administration is ordering Johnson & Johnson’s DePuy Orthopedics unit to halt sales of its Corail Hip System because the company is marketing it for an unapproved use, according to a warning letter made public on Tuesday.
